Multiplex Assay Kit for Alpha-1-Microglobulin (a1M) ,etc. by FLIA (Flow Luminescence Immunoassay)

AMBP; UTI; HCP; EDC1; HI30; IATIL; ITILC; ITI; ITIL; Alpha 1 Microglobulin/Bikunin Precursor; Growth-inhibiting protein 19; Uristatin; Uronic-Acid-Rich Protein; Trypstatin

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Alpha-1-Microglobulin (a1M) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Alpha-1-Microglobulin (a1M) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Alpha-1-Microglobulin (a1M) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Alpha-1-Microglobulin (a1M) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 96-105 101
EDTA plasma(n=5) 78-105 83
heparin plasma(n=5) 96-104 99

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Alpha-1-Microglobulin (a1M) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Alpha-1-Microglobulin (a1M) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Alpha-1-Microglobulin (a1M) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 78-91% 85-103% 96-104% 96-105%
EDTA plasma(n=5) 95-102% 80-99% 87-101% 93-103%
heparin plasma(n=5) 81-94% 86-96% 81-101% 82-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:a1M) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Diabetes Technology & Therapeutics Proteomic Identification of Human Urinary Biomarkers in Diabetes Mellitus Type 2 Liebert: 20100078
Journal of Pharmaceutical and Biomedical Analysis Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2 PubMed: 21130593
BioMed Research International Proteomic Profiling for Peritoneal Dialysate: Differential Protein Expression in Diabetes Mellitus PubMed: PMC3679811
Mainz Identifizierung neuer potentieller Biomarker für das Kolonkarzinom sowie dessen Vorstufen Info:Source
Cellular Physiology and Biochemistry Activated Α7nachr Improves Postoperative Cognitive Dysfunction and Intestinal Injury Induced by Cardiopulmonary Bypass in Rats: Inhibition of the Proinflammatory … Pubmed:29672286
Journal of Clinical Medicine Urinary Proteomics for the Early Diagnosis of Diabetic Nephropathy in Taiwanese Patients Pubmed: 30486327
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APA217Hu61 Active Alpha-1-Microglobulin (a1M) Cell culture; Activity Assays.
APA217Hu62 Active Alpha-1-Microglobulin (a1M) Cell culture; Activity Assays.
EPA217Hu61 Eukaryotic Alpha-1-Microglobulin (a1M) Positive Control; Immunogen; SDS-PAGE; WB.
EPA217Hu62 Eukaryotic Alpha-1-Microglobulin (a1M) Positive Control; Immunogen; SDS-PAGE; WB.
RPA217Hu01 Recombinant Alpha-1-Microglobulin (a1M) Positive Control; Immunogen; SDS-PAGE; WB.
PAA217Hu01 Polyclonal Antibody to Alpha-1-Microglobulin (a1M) WB
LAA217Hu71 Biotin-Linked Polyclonal Antibody to Alpha-1-Microglobulin (a1M) WB; IHC; ICC.
MAA217Hu22 Monoclonal Antibody to Alpha-1-Microglobulin (a1M) WB; IHC; ICC; IP.
SEA217Hu ELISA Kit for Alpha-1-Microglobulin (a1M) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA217Hu CLIA Kit for Alpha-1-Microglobulin (a1M) Chemiluminescent immunoassay for Antigen Detection.
LMA217Hu Multiplex Assay Kit for Alpha-1-Microglobulin (a1M) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.